Transformational Opportunities: UBS Suggests 2 Longevity Stocks to Buy as the $8T Aging Boom Accelerates [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
The U.S. population itself is aging, and that shift is starting to ripple far beyond personal milestones. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential The Chief Investment Office at UBS views this trend as a foundation for long-term portfolio positioning. It frames “longevity” as a structural theme – a growing, aging population with evolving needs, particularly in areas like healthcare. Healthcare is set to play a central role among longevity-focused investments, while other sectors will need to adjust to changing demand patterns. The opportunity is substantial for companies and investors that recognize the broader trend. Laying out the situation, the UBS team writes: “We estimate that the annual longevity market opportunity was USD 5.3 trillion in 2023 and will grow by an incremental USD 2.5 trillion
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Fidelity Stock Selector Mid Cap Fund Q4 2025 Scorecard: Buys, Sells, And Standouts [Seeking Alpha]Seeking Alpha
- Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- 2 Defensive Healthcare Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Is Abbott Laboratories (ABT) A Good Stock To Buy Now? [Yahoo! Finance]Yahoo! Finance
- Abbott acquisition of Exact Sciences set to close on March 23, 2026PR Newswire
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 3/13/26 - Form ARS
- 3/13/26 - Form DEF
- 3/13/26 - Form DEFA14A
- ABT's page on the SEC website